Scarica l'app Stockscreener
30.18
0.10%
0.03
Dopo l'orario di chiusura:
30.18
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$30.15
Aprire:
$29.74
Volume 24 ore:
842.44K
Relative Volume:
1.17
Capitalizzazione di mercato:
$1.32B
Reddito:
$596.57M
Utile/perdita netta:
$-109.88M
Rapporto P/E:
-7.7902
EPS:
-3.8741
Flusso di cassa netto:
$28.72M
1 W Prestazione:
-3.21%
1M Prestazione:
-9.45%
6M Prestazione:
+32.48%
1 anno Prestazione:
+3.07%
Intervallo 1D:
$29.64
$30.38
Intervallo di 1 settimana:
$29.64
$31.66
Portata 52W:
$15.93
$41.73
Azenta Inc Stock (AZTA) Company Profile
Nome
Azenta Inc
Settore
Industria
Telefono
(978) 262-2400
Indirizzo
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
30.18 | 1.32B | 596.57M | -109.88M | 28.72M | -3.8741 |
ISRG
Intuitive Surgical Inc
|
360.46 | 124.79B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
176.42 | 48.98B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.55 | 33.08B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.58 | 31.73B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
32.39 | 29.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-19 | Reiterato | Needham | Buy |
| 2025-10-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-08-06 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2025-07-22 | Ripresa | Stephens | Equal-Weight |
| 2024-12-18 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2024-04-04 | Iniziato | Jefferies | Hold |
| 2024-02-01 | Reiterato | B. Riley Securities | Buy |
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2023-05-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-02-09 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-03-31 | Ripresa | B. Riley Securities | Buy |
| 2022-03-21 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Azenta Inc Borsa (AZTA) Ultime notizie
Azenta, Inc. (AZTA) accounting chief reports owning no stock - Stock Titan
Azenta (NASDAQ: AZTA) Secures Early $35M Vendor Loan Repayment, Finalizing $63M Cash Purchase - Kalkine Media
Azenta Completes B Medical Divestiture With Loan Repayment - theglobeandmail.com
Azenta Secures Full $35M Vendor Loan Repayment from B Medical Buyer Ahead of Schedule - Kalkine Media
Azenta completes B Medical sale as vendor loan repaid (AZTA) - Seeking Alpha
Azenta receives full $35M vendor loan repayment, completing $63M sale of B Medical Systems. - Pluang
Azenta Receives Full $35 Million Vendor Loan Repayment From B Medical Sale - citybiz
Azenta receives full $35.37M repayment, completes $63M sale of B Medical Systems - TradingView
A $63 million sale is now fully paid in cash. Azenta received the final $35 million. - Stock Titan
Azenta CEO resignation sparks 12% stock drop am... - Pluang
How Investors Are Reacting To Azenta (AZTA) CEO Resignation And Interim Leadership Change - simplywall.st
Azenta CEO Resigns as Interim Leader Reassures Outlook - theglobeandmail.com
Why Azenta (AZTA) Stock Is Down Today - Barchart.com
Azenta CEO John Marotta Steps Down; Dr. Martin Madaus Named Interim CEO - Kalkine Media
Azenta appoints interim CEO as John Marotta resigns By Investing.com - Investing.com Nigeria
Azenta Names Martin Madaus Interim CEO, Reaffirms Revenue Guidance - citybiz
AZENTA ANNOUNCES LEADERSHIP TRANSITION - marketscreener.com
ETFs Investing in Azenta, Inc. Stocks - TradingView
Azenta (AZTA) Results Check: EPS Beats Its Estimate for the Current Session; Price Move: Shares Move Lower 1.79% in the Available RecordNew Analyst Coverage - vinanet.vn
Azenta, Inc. Earnings Call Balances Growth And Strain - theglobeandmail.com
Azenta, Inc.: Financial Data Forecasts Estimates and Expectations | BA3 | US1143401024 - marketscreener.com
Azenta: Needs To Overcome A Few Hurdles If The Rally Is To Continue (NASDAQ:AZTA) - Seeking Alpha
AZTA Q2 2026 Earnings: EPS Surpasses Estimates by 37.8% on Operational StrengthReturn On Equity - vinanet.vn
Azenta, Inc. (AZTA) Stock Forecasts - Yahoo Finance
Azenta Inc. (AZTA) Edges Higher to $33.53 as Life Sciences Tools Sector StabilizesExhaustion Gap - vinanet.vn
The 5 Most Interesting Analyst Questions From Azenta’s Q2 Earnings Call - Yahoo! Finance Canada
Azenta (AZTA) Is Up 11.5% After Returning To Profit And Raising Revenue OutlookHas The Bull Case Changed? - webull.com
Azenta (AZTA) SVP Pirogova has 1,085 shares withheld for tax obligations - Stock Titan
Azenta, Inc. Announces Appointment of Erik J. Bello as Chief Accounting Officer, Effective August 31, 2026 - marketscreener.com
Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth in the Healthcare Sector with a 4.41% Potential Upside - DirectorsTalk Interviews
Azenta (AZTA) Holds Steady at $33.39 as Shares Trade Mid-Range Between Support and ResistancePCR Moving Average - vinanet.vn
Weekly Recap: Azenta, Inc. Q3 revenue gain and analyst target raises - TradingView
Azenta Inc (AZTA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues - The National Law Review
Azenta Inc (AZTA) Stock News Today - TradingKey
Azenta, Inc. $AZTA Stake Cut by Quantinno Capital Management LP - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Azenta, Inc. (AZTA) And Encourages Investors to Connect - The National Law Review
Azenta (AZTA) Is Up 6.7% After Raising 2026 Guidance And Completing $50M Buyback – What’s Changed - Yahoo Finance
Multi-Manager Small Cap Equity Strategies Fund's Azenta Inc(AZTA) Holding History - GuruFocus
Azenta, Inc. 3Q 2026: Revenue $161.18M, EPS $0.05— 10-Q Summary - TradingView
Azenta (Nasdaq: AZTA) sells B Medical unit, books $149M impairment - Stock Titan
Life Science Funding Weakness Hit Azenta’s (AZTA) Outlook - Yahoo Finance
Azenta, Inc. $AZTA Shares Sold by Bank of New York Mellon Corp - MarketBeat
Arrowstreet Capital Limited Partnership Buys New Position in Azenta, Inc. $AZTA - MarketBeat
Azenta (AZTA) Drops 3%: Approaching Key Support at $29.33 Amid Sector HeadwindsIchimoku Entry - vinanet.vn
Azenta Inc (AZTA) (Q3 2026) Earnings Call Highlights: Organic Gr - GuruFocus
Azenta, Inc. Stock 12‑Month Price Target Raised to $33.8, Implies 12% Upside - TradingView
Azenta Inc (AZTA) (Q3 2026) Earnings Call Highlights: Organic Growth Surges 9% Amid Strategic ... - Yahoo Finance
Azenta Releases Q3 2026 Financial Results - AlphaStreet
Azenta (NASDAQ:AZTA) Price Target Raised to $37.00 - MarketBeat
Earnings call transcript: Azenta tops Q3 2026 estimates, shares edge higher - Investing.com
Azenta Inc Azioni (AZTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
14.67%
2.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):